Benomar, A., Yahyaoui, M., Meggouh, F., et al., (2002) Clinical comparison between AVED patients with (744 Del A) mutation and Friedreich ataxia with GAA expansion in 15 Moroccan families. Journal of the Neurological Sciences, 198, 25-29. doi:10.1016/S0022-510X(02)00057-6

has been cited by the following article:

• TITLE: Vitamin E in ataxia and neurodegenerative diseases: A review

  AUTHORS: Fatima. Imounan, Naima. Bouslam, Jehanne. Aasfara, Kaoutar. El alaoui, Wafa. Regragui, El Hachmia. Ait Benhaddou, Ahmed. Bouhouche, Ali. Benomar, Mohamed. Yahyaoui

  KEYWORDS: Vitamin E; Neurodegenerative Diseases; Ataxia with Vitamin E Deficiency

  JOURNAL NAME: World Journal of Neuroscience, Vol.2 No.4, November 27, 2012

  ABSTRACT: Vitamin E is one of the most important lipid-soluble antioxidants. It is essential for the neurological function but its role in the central nervous system has not fully been elucidated. It is known that tocopherol acts in protecting cell membranes from oxidative damage and it can act as an anti-in?ammatory agent, which may also be neuroprotective, as well as regulating speci?c enzymes. There is growing evidence that oxidative stress plays a key role in the pathophysiology of several neurodegenerative disorders. These diseases are defined by the progressive loss of speci?c neuronal cell populations and are associated with protein aggregates. We reviewed some aspects related to the role of antioxidant properties of Vitamin E in preventing and/or curing neurodegenerative disorders such as the Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, ataxia, tardive dyskinesia and Huntington’s disease.